(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease
Bloomberg Intelligence
3,286 clip(s)
Intel Shares Fall on Report Nvidia Halts Production Test
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
Larry Ellison’s Guarantee Ups Warner Bros. Stakes to a New Level